ATE218582T1 - Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen - Google Patents

Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen

Info

Publication number: ATE218582T1
Authority: AT; Austria
Prior art keywords: preparation; pharmaceutical compositions; cyclosporine derivatives; derivatives; cyclosporine
Prior art date: 1996-12-24

Application number

AT97952999T

Other languages

English (en)

Inventor

Jean-Claude Barriere

Georges Bashiardes

Jean-Christophe Carry

Michel Evers

Bruno Filoche

Serge Mignani

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-24

Filing date

1997-12-23

Publication date

2002-06-15

1997-12-23 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2002-06-15 Application granted granted Critical

2002-06-15 Publication of ATE218582T1 publication Critical patent/ATE218582T1/de

Links

PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical class CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
208000005074 Retroviridae Infections Diseases 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT97952999T 1996-12-24 1997-12-23 Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen ATE218582T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9615955A FR2757521B1 (fr)	1996-12-24	1996-12-24	Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR1997/002406 WO1998028330A1 (fr)	1996-12-24	1997-12-23	Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number	Publication Date
ATE218582T1 true ATE218582T1 (de)	2002-06-15

Family

ID=9499088

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97952999T ATE218582T1 (de)	1996-12-24	1997-12-23	Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen

Country Status (14)

Country	Link
US (1)	US5994299A (de)
EP (1)	EP0951474B1 (de)
JP (1)	JP4146518B2 (de)
AT (1)	ATE218582T1 (de)
AU (1)	AU5669398A (de)
DE (1)	DE69713152D1 (de)
DK (1)	DK0951474T3 (de)
ES (1)	ES2178038T3 (de)
FR (1)	FR2757521B1 (de)
MA (1)	MA26458A1 (de)
PT (1)	PT951474E (de)
TN (1)	TNSN97212A1 (de)
WO (1)	WO1998028330A1 (de)
ZA (1)	ZA9711607B (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030220234A1 (en)	1998-11-02	2003-11-27	Selvaraj Naicker	Deuterated cyclosporine analogs and their use as immunodulating agents
WO1999065933A1 (en) *	1998-06-12	1999-12-23	C-Chem Ag	Novel cyclosporins
FR2780061B1 (fr) *	1998-06-22	2001-09-07	Rhone Poulenc Rorer Sa	Nouveau procede de preparation de derives de cyclosporine
USRE40987E1 (en)	1998-07-01	2009-11-17	Debiopharm S.A.	Cyclosporin with improved activity profile
US6254860B1 (en) *	1999-04-13	2001-07-03	Allergan Sales, Inc.	Ocular treatment using cyclosporin-A derivatives
EP2269654A3 (de)	1999-08-24	2011-04-13	Cellgate Inc.	Verbesserung des Verabreichung von Arzneimitteln durch und in epitheliale Gewebe rch Verwendung von Oligoarginin-Gruppen
KR100465012B1 (ko) *	2001-05-11	2005-01-13	주식회사 엘지생활건강	모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
PT1435910E (pt) *	2001-10-19	2009-09-07	Isotechnika Inc	Novos pré-concentrados de microemulsão de análogos da ciclosporina
DE60231570D1 (de)	2001-10-19	2009-04-23	Isotechnika Inc	Synthese von Cyclosporinanalogen
KR20040039622A (ko) *	2002-11-04	2004-05-12	주식회사 엘지생활건강	모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
US6987090B2 (en) *	2002-05-09	2006-01-17	Lg Household & Health Care Ltd.	Use of 3-position cyclosporin derivatives for hair growth
AU2004222306A1 (en)	2003-03-17	2004-09-30	Albany Molecular Research, Inc.	Novel cyclosporins
GB0320638D0 (en) *	2003-09-03	2003-10-01	Novartis Ag	Organic compounds
US7780973B2 (en) *	2003-12-15	2010-08-24	Ethicon Endo-Surgery, Inc.	Method and device for minimally invasive implantation of biomaterial
US20050142161A1 (en) *	2003-12-30	2005-06-30	Freeman Lynetta J.	Collagen matrix for soft tissue augmentation
JP2008506648A (ja) *	2004-07-14	2008-03-06	ノバルティスアクチエンゲゼルシャフト	Ｃ型肝炎（ｈｃｖ）処置のためのシクロスポリンとペグ化インターフェロンの組合せ剤の使用
KR100597309B1 (ko)	2004-09-17	2006-07-05	주식회사 핸슨바이오텍	세베키아 베니하나를 이용한 [감마 히드록실메틸루신4] 사이클로스포린 a의 제조방법
WO2006039163A2 (en)	2004-09-29	2006-04-13	Amr Technology, Inc.	Cyclosporin alkyne analogues and their pharmaceutical uses
JP2008514702A (ja)	2004-09-29	2008-05-08	エーエムアールテクノロジーインコーポレイテッド	新規シクロスポリン類似体およびそれらの薬学的使用
US7196161B2 (en) *	2004-10-01	2007-03-27	Scynexis Inc.	3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
SI1802650T1 (sl) *	2004-10-01	2012-03-30	Scynexis Inc	Eter in tioeter substituirani ciklosporinski derivati za zdravljenje in preventivo pred infekcijami s hepatitisom c
WO2006041631A2 (en)	2004-10-06	2006-04-20	Amr Technology, Inc.	Novel cyclosporin alkynes and their utility as pharmaceutical agents
US7691812B2 (en)	2004-11-04	2010-04-06	Trustees Of The University Of Pennsylvania	Methods for inhibiting growth of prolactin-responsive cancer cells with cyclosporine A or other cyclophilin inhibitors
US7897565B2 (en) *	2004-12-23	2011-03-01	Novartis Ag	Compositions for HCV treatment
RU2007128098A (ru) *	2004-12-23	2009-01-27	Новартис АГ (CH)	Соединения для лечения инфекций, вызываемых вирусами семейства flaviviridae
CN105169369B (zh) *	2005-09-30	2019-10-18	中美华世通生物医药科技（武汉）有限公司	治疗和预防丙型肝炎感染的方法和药物组合物
CN101316606B (zh) *	2005-09-30	2015-05-27	西尼克斯公司	治疗和预防丙型肝炎感染的方法和药物组合物
CA2623864C (en)	2005-09-30	2014-12-16	Scynexis, Inc.	Arylalkyl and heteroarylalkyl derivatives of cyclosporine a for the treatment and prevention of viral infection
US7696166B2 (en)	2006-03-28	2010-04-13	Albany Molecular Research, Inc.	Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en)	2006-03-28	2010-04-13	Albany Molecular Research, Inc.	Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
EP2023918B1 (de)	2006-05-19	2011-03-23	Scynexis, Inc.	Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
KR101089112B1 (ko) *	2006-06-02	2011-12-06	피씨 제스띠옹 에스.아.에스.	활성 전자 관리
SG175621A1 (en) *	2006-10-12	2011-11-28	Novartis Ag	Use of modified cyclosporins
US7576057B2 (en)	2006-11-20	2009-08-18	Scynexis, Inc.	Cyclic peptides
WO2008127613A1 (en) *	2007-04-11	2008-10-23	Scynexis, Inc.	New pharmaceutical compositions
WO2009042892A1 (en)	2007-09-26	2009-04-02	Oregon Health & Science University	Cyclic undecapeptides and derivatives as multiple sclerosis therapies
WO2009148615A1 (en) *	2008-06-06	2009-12-10	Scynexis, Inc.	Cyclosporin analogs and their use in the treatment of hcv infections
JP5820722B2 (ja)	2008-06-06	2015-11-24	スシネキスインク	シクロスポリン類似体及びｈｃｖ感染の治療におけるその使用
JP5661035B2 (ja) *	2008-07-10	2015-01-28	アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ	眼および皮膚の疾患および症状の治療用のシクロスポリン誘導体
DE102008060549A1 (de)	2008-12-04	2010-06-10	MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.	Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
CA2748389A1 (en)	2008-12-31	2010-07-08	Scynexis, Inc.	Derivatives of cyclosporin a
AU2010203656A1 (en) *	2009-01-07	2011-07-21	Scynexis, Inc.	Cyclosporine derivative for use in the treatment of HCV and HIV infection
CA2763207A1 (en)	2009-05-27	2010-12-02	Allergan, Inc.	Cyclosporin derivatives for treating inflammatory diseases and conditions
KR20120125610A (ko)	2009-12-30	2012-11-16	싸이넥시스, 인크.	시클로스포린 유사체
CN107007815A (zh)	2010-07-16	2017-08-04	美国科技环球有限公司	新颖的环孢霉素a衍生物在病毒感染的治疗和预防中的应用
WO2012021796A2 (en)	2010-08-12	2012-02-16	S&T Global, Inc.	Novel cyclosporin derivatives for the treatment and prevention of a viral infection
MX2013004062A (es) *	2010-10-12	2013-07-22	Allergan Inc	Analogos de ciclosporina.
RU2013119869A (ru)	2010-10-12	2014-11-20	Аллерган, Инк.	Аналоги циклоспорина
US9890198B2 (en)	2010-12-03	2018-02-13	S&T Global Inc.	Cyclosporin derivatives and uses thereof
LT2651965T (lt)	2010-12-15	2019-01-10	Contravir Pharmaceuticals, Inc.	Ciklosporino analogo molekulės su modifikuotomis 1 ir 3 aminorūgštimis
EP2705856A1 (de)	2012-09-07	2014-03-12	Deutsches Zentrum für Neurodegenerative Erkrankungen e.V.	Verbindungen zur Behandlung von neurodegenerativen Erkrankungen
WO2020037530A1 (en) *	2018-08-22	2020-02-27	Waterstone Pharmaceuticals (Wuhan) Co., Ltd.	Crystalline form of compound and uses thereof in medicine
WO2020118714A1 (en)	2018-12-14	2020-06-18	Waterstone Pharmaceuticals (Wuhan) Co., Ltd.	Maleate of scy-635 and uses thereof in medicine
WO2020118715A1 (en) *	2018-12-14	2020-06-18	Waterstone Pharmaceuticals (Wuhan) Co., Ltd.	Salts of scy-635 and uses thereof in medicine
WO2023102847A1 (en) *	2021-12-09	2023-06-15	Waterstone Pharmaceuticals (Wuhan) Co., Ltd.	Ws635 uses thereof in medicine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0194972B1 (de) *	1985-03-11	1992-07-29	Sandoz Ag	Cyclosporine
US4814323A (en) *	1986-03-25	1989-03-21	Andrieu J M	Process for the treatment and the prevention of AIDS and other disorders induced by the LAV/HTLV III virus
DE69124459T3 (de) *	1990-11-02	2001-05-31	Novartis Ag, Basel	Zyklosporine
NZ315324A (en) *	1995-07-17	1999-10-28	Chem Ag C	Cyclosporin derivatives with anti-hiv effect

1996
- 1996-12-24 FR FR9615955A patent/FR2757521B1/fr not_active Expired - Fee Related
1997
- 1997-12-19 MA MA24907A patent/MA26458A1/fr unknown
- 1997-12-23 TN TNTNSN97212A patent/TNSN97212A1/fr unknown
- 1997-12-23 AU AU56693/98A patent/AU5669398A/en not_active Abandoned
- 1997-12-23 JP JP52849098A patent/JP4146518B2/ja not_active Expired - Lifetime
- 1997-12-23 ZA ZA9711607A patent/ZA9711607B/xx unknown
- 1997-12-23 DE DE69713152T patent/DE69713152D1/de not_active Expired - Lifetime
- 1997-12-23 PT PT97952999T patent/PT951474E/pt unknown
- 1997-12-23 WO PCT/FR1997/002406 patent/WO1998028330A1/fr not_active Ceased
- 1997-12-23 AT AT97952999T patent/ATE218582T1/de not_active IP Right Cessation
- 1997-12-23 ES ES97952999T patent/ES2178038T3/es not_active Expired - Lifetime
- 1997-12-23 EP EP97952999A patent/EP0951474B1/de not_active Expired - Lifetime
- 1997-12-23 US US08/997,612 patent/US5994299A/en not_active Expired - Lifetime
- 1997-12-23 DK DK97952999T patent/DK0951474T3/da active

Also Published As

Publication number	Publication date
DE69713152D1 (de)	2002-07-11
FR2757521B1 (fr)	1999-01-29
JP4146518B2 (ja)	2008-09-10
DK0951474T3 (da)	2002-09-16
JP2001507347A (ja)	2001-06-05
MA26458A1 (fr)	2004-12-20
US5994299A (en)	1999-11-30
ES2178038T3 (es)	2002-12-16
EP0951474B1 (de)	2002-06-05
ZA9711607B (en)	1998-06-24
FR2757521A1 (fr)	1998-06-26
EP0951474A1 (de)	1999-10-27
AU5669398A (en)	1998-07-17
WO1998028330A1 (fr)	1998-07-02
TNSN97212A1 (fr)	2005-03-15
PT951474E (pt)	2002-11-29

Legal Events

Date	Code	Title	Description
2002-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE218582T1 (de)	2002-06-15	Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
ATE218580T1 (de)	2002-06-15	Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
DE69829175D1 (de)	2005-04-07	Cyclosporinderivate, deren herstellung und pharmazeutische zubereitungen
DE69713151D1 (de)	2002-07-11	Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
BG103945A (bg)	2000-07-31	Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а
AP9801378A0 (en)	2000-04-29	9-amino-3- keto erythromycin derivatives.
ATE165100T1 (de)	1998-05-15	Peptide mit endothelin antagonistischer aktivität, deren herstellung und pharmazeutische zusammensetzungen
DE69720551D1 (de)	2003-05-08	Makrozyklische derivate von erythromycin a und b mit 13 ringatomen
RU95106362A (ru)	1996-12-27	Производные липопептида, способ их получения, содержащая их фармацевтическая композиция и способ ее получения
GR3019274T3 (en)	1996-06-30	Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
WO2001005386A3 (en)	2001-07-19	Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
ES2192789T3 (es)	2003-10-16	Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
RU94040865A (ru)	1996-08-10	Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью
BR0011845A (pt)	2002-03-05	Complexo farmacêutico
PT952157E (pt)	2003-11-28	Derivados 9a, 11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina
MX9605312A (es)	1998-02-28	Dipsipeptidos ciclicos antifungales.